Cortica Inc., a US physician-led, coordinated and tech-enabled care model focused on autism and other neurodiverse conditions, received a strategic investment from the Autism Impact Fund (AIF).
The amount of the deal was not disclosed.
The company intends to use the funds to bring its “whole-child” medical and behavioral care model to more families across the country.
Led by Neil Hattangadi, M.D., Co-Founder and CEO, Cortica integrates the latest medical advances from leading academic medical centers, with behavioral analysis, developmental therapies, and family support, enabled by Axon, its tech infrastructure for care coordination and data capture.
The company’s centers span five states, including California, Illinois, New Jersey, New York and Texas, with each location led by preeminent neurologists and other physicians. As part of its platform, Cortica is running multiple clinical trials including several with funding from the National Institutes of Health and company sponsors, across neuroimaging, neuromodulation, molecular diagnostics, biotech therapeutics, and digital therapeutics.